Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CCND3 |
| Upstream (Parents) |
|---|
| (<<) ATP2A2 → CCND3 |
| (<<) CPD → CCND3 |
| (<<) EPHB3 → CCND3 |
| (<<) GPX7 → CCND3 |
| (<<) HK2 → CCND3 |
| (<<) LRP6 → CCND3 |
| (<<) LYPLA2 → CCND3 |
| (<<) MAPK13 → CCND3 |
| (<<) MAPK6 → CCND3 |
| (<<) PCSK7 → CCND3 |
| (<<) PPIB → CCND3 |
| (<<) PYGB → CCND3 |
| (<<) TSPAN3 → CCND3 |
| Downstream (Children) |
|---|
| CCND3 → CASP9 (>>) |
| CCND3 → NFKBIB (>>) |
| CCND3 → PDIA4 (>>) |
| CCND3 → PPP3CC (>>) |
| CCND3 → THRB (>>) |
